<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 221 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page220.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=221">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 221 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 221</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=221"><img src="../thumb/221.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>186 / 2020-04                                                  Gastro-Intestinal Tract- 12.8 / 12.9 / 12.10
   2 caps midd.& 2 caps in even. Over 100 kg: 2 caps 3x/day. If clinic.  Dosage: 2 g at night per rectum.  persens.pneumonit., tachycard., hypo-/hypertens., pharyngolaryng.
   sympt.worsen.at begin.of treatm., cont.ther.with 1 cap dly.dos.& then   (S3) SUPPS. [P/S] Z/11.10/206.  pain, pancreatit., abnorm. LFT, skin reacts.incl.prurigo, Stev.Johns.
   incr.grad.by one cap.dly each wk until.dos.in regim.reach.  Indications: Mild to mod.proctit.& proctosigmoidit. in ulcerat.colit.  syndr., alopec., arthralg., back-/abdom.pain, asthen., fatig., pyrex.,
   Contraindications: Ac.gall-bladd./bil.tract inflamm., common bile/  824135-008: 500 mg, 20, R396,24  fac.oed., bld.dyscras., neuropathy, pericardit., myocardit., allerg.al-
   cyst.duct occlus., pept.ulc. dis., freq.bil.colic episod., non-funct.gall-  Dosage: One supp.per rectum up to 3x/day.aft. defaecat. Reduc.  veolit., bronchosp., cholelithias., hepatit., angioed., SLE-like syndr.,
   bladd., radio-opaq./ calcif.gallston., safety in pregn.& lactat.not est.  as condit.improves.  myalg., interstit.nephrit., nephrot. syndr., ren.impairm./-fail., bloody
   Side effects: Pasty stool, diarrh., sev.(R) side upp.abdom.pain, gallst.  Contraindications: Salicyl.sens., sev.ren. impairm., liv.impairm.,   diarrh., cramp., card.hypersens.reacts.
   calcificat., poss. decompensat. of hepat.cirrhos.in PBC, urticar, prurit.  gastric & duod.ulc., bleed. tendenc., safety & effic.pregn.& lactat.  Warnings and special precautions Excret.in breast milk, elderly,
               st
   Special precautions: Dur.1  3 mnths liv.funct. test.to be monit.  not est., lact.intol.for tabs.  mild to mod.ren.impairm., ren. funct. eval.bef. nit.& at least 2x/yr dur.
   every 4 wks, thereaft.3 mnthly., concom.ciclosporin, adeq.contra-  Side effects: Anaem., headache, dizzin., tinnit., paraesthes., vom-  ther., chron. lung funct.impairm.esp.asthma, hepat.impairm., concom.
   cept.in women of childbear.age, pregn. exclud.bef.init.treatm., con-  it., naus., dyspeps., abdom.pain, diarrh., flatul., rash., prurit., urticar.,   known nephrotox.agents incl.NSAID’s/ azathioprine, concom.6-
   com. agents metabol.via cytochrome P450 3A enzyme, poss.clinic.  arthralg., myalg., fev., bld.dyscras., periph.neuropathy, vertigo, peri-  mercaptopurine, prothromb. time/INH monit.with coumar. antico-
   sympt.worsen.at beg.ther.    cardit., myocardit., dyspn., pneumon., interstit.-/eosinophil.pneumon.,   ags., sulphasalazine cross-sens., organ./ funct. upp.GI obstruct.,
   Drug interactions: Reduc.absorpt.with concom. cholestyramine/  lung disord., chest pain, cough, bronchosp., alveolit., pulm. eosino-  poss.ther.-induc. nephrotoxic., discont.ther.if ser.bld.dyscras.devel./
   colestipol/Al contain.antacids (admin.at least 2 hrs bef./aft.), ciclo-  phil., lung infiltrat., colit.sympt.exacerbat., pancreatit., LF paramet.  ac.intol.syndr.susp., condits.predispos.to myo-/pericardit.developm.
   sporin absorpt. incr. from intest., poss.reduc.ciprofloxacin absorpt., re-  changes, hepatit., alopec., Stev.John.syndr., erythema multiforme,   Drug interactions: Thiopurine methyltransferase inhib., poss.decr.
   duc.peak plasma conc.and AUC of nitrendipine, induc.drug-metabolis.  bulbous skin reacts., rash, lupus-like syndr.with pericardit.& pleu-  anticoag.activ.with coumar. anticoags., consid.alternat.select.assay
   enzyme cyto chromosome P450 3A4.  ropericardit.as promin.sympts as well as rash & arthralg., imp.ren.  when meas.urin.normetanephr.by liq.chromatography with elctro-
   URSOTAN, Sanofi-Aventis [P/S]  funct., interstit. nephrit., ren.fail., nephrot.syndr., hypersens. reacts.,   chemic.detect.as spuriously elev.test results record.
   Ursodeoxycholic.acid         revers.oligosperm. Enema & supps also: anal irrit.  See also MDR page 94.
   Indications: Dissolut.radiolucent cholestrol gallstones in funct.  Warnings and special precautions Ren. impairm., rais.bld.urea/  PENTASA, Ferring [P/S] &
   gallbladders.                proteinur., consid.induc. nephrotox. if ren.impairm.develops dur.ther.,   Mesalazine
   (S3) TABS, N/34/203          monit. ren.funct.bef.& 4 wkly x12 wks.dur.ther. extend. to every 6   Indications: Treatm of mild to mod ulcerat. colit. & maint.of it’s remiss.
   774243-007:100 mg, 180, R1 445,15  mnths & then annually every 5 yrs. in absence of ac.allerg.ren.re-  (S3) TABS, [P/S] 33/11/0088
   Dosage: Treatm.durat.accord.to size & dissolut. rate of gallstones.  spons., complete bld count bef.& 4 wkly x12 wks.dur. ther. & then   890775-004: 500 mg, 100, R641,35
   6 tabs.dly.in 3 div.dos.aft.meals.  quarterly if results norm., discont.if ren. impairm./ bld.dyscras.evid.,   Dosage: Do not chew/halve. May be dispers.in 50 ml cold water.
   Contraindications: Bile acid allergy, pept.ulc.dis., chron.liv.dis.,   pulm.dis.in partic. asthma, myo-/pericardit.of allerg. background,   Ulcerat.colit: Adults: Ac.treatm: Indiv. Up to 4 g/day admin.once
   inflamm.small intest.& colon dis., bile duct obstruct., radio-opaq/   do not re-introduc.in case of mesalazine-induc. card.hypersens.,   dly.or in 4 div.dos. Recomm. maint: Indiv.2 g once dly or in 4 div.dos.
   calcif./bile pigment stones/ non funct.gallballers, other gallstone   sulphasalazine hypersens.hist., elderly, limit. documentat.for eff.in   Childr.6 yrs & old: Indiv. Start with 30-50 mg/ kg/ day in div.dos. Max:
   complicat., pregn.           childr.6-18 yrs., concurr. preps. which lower stool pH., INR monit.with   75 mg/kg/day in div.dos. Tot.dos.not to exceed 4 g/day. Recomm.
   Side effects: GI disords., dyspeps., calcificat.of cholesterol stones,   concom. warfar, poss.life threat.infect.with concom. azathioprine/6-  maint: Indiv. Start with 15-30 mg/kg/day in div.dos. Tot. dos.not to ex-
   dose-relat.diarrh., prurit.  mercaptopurine & thioguanine, poss.incr.ren.react.risk with known   ceed 2 g/day. In childr.it’s gen. recomm. to give half adult dos to those
   Special precautions: Monit.serum enzyme levels & perform   nephrotox.agents eg NSAID’s/azathioprine  with body weight up to 40 kg and norm.adult dos.for those over 40 kg.
   liv.funct.test.              Drug interactions: Prep.low.stool pH prev.act. ingred. rel., poss.  (S3) SUPPS, [P/S] A40/11/0374
   Drug interactions: Concurr.oestrog.hormones/ OC./antihyper-  decr.anticoag.eff.of warfar., immunosuppress. effs.of azathioprine/6-  Indications: Mild to mod.ulcerat.proctit.where les.within 30 cm
   lipidem./neomycin progestins decr. ability to dissolve cholestr.gall-  mercaptopurine & thioguanine incr., reduc. uricosur. acitiv.of sulfin-  of anal verge
   stones., bile acid bind.drugs decr.absorpt.  pyrazone & diuret.eff.of furosemide  714134-001: 1 g, 28, R1 101,17
   Warnings: Sulfation defic.congenit./acquir.poss. predispose pt.to   ENTOCORD, Equity [N/P/S in C]  Dosage: Ulcerat.proctit: Ac.treatm: 1 supp dly. Maint.treatm:
   lithocholate-induc.liv.damage.  Budesonide.                1 supp.3x/wk.on non-consecut. days
                                Indications: Ulcerat.colit.involv.rectum & sigmoid colon.  (S3) ENEMA, [P/S] 44/11/0888. 1 g/100 ml.
                                (S4) ENEMA (DISPERS.TABS.& VEHICLE). [N/P/S in C]   Indications: Treatm.of ulcerat.proctosigmoidit.& left-side colit.
   12.9   Suppositories and anal    29/11.8/0638. 0,02 mg/ml  721267-001: 7x100 ml, R519,90
                                                              Dosage: 1 enema rectally at bedt.
                                824593-006: 2,3 mg, 7 tabs.+7 bott.of vehicle, R499,97
          ointments             Dosage: Adults: 1 enema nightly for 4 wks.just bef.bedt. Full eff.  (S3) SACHETS (PROLONG.REL.GRAN.), [P/S] 43/11/0013, 0014
                                                              Indications: Adults & childr.6 yrs & over: Mild to mod.ulc.colit.
                                observ.in 2-4 wks.. If remiss.not achiev.within 4 wks.prolong treatm.
   SCHERIPROCT (MDR Listing)    to 8 wks. Prepare just bef.use.  treatm.& remiss.maint., mild to mod.Chron’s dis.
                                (S4) CAPS. [N/P/S in C] 31/21.5.1/0215.  722335-001: 1 g, 120, R1 539,84
   SCHERIPROCT, (Adcock Ingra) Bayer [N/P/S in C] &  Indications: Induct.of remiss.in pts.with mild to mod.Crohn’s dis.  722336-001: 2 g, 60, R1 539,84
   Prednisolone caproate 1,9 mg, cinchocaine HCl 5 mg/g.  involv.ileum & or ascend.colon.  Dosage: Empty cont. on tong.& swall.with water/ juice without
   Indications: Short-term sympt.relief in haemorrh., anal fiss.,   838896-006: 3 mg, 100, R1 127,73  chew.grans.
   prurit.ani.                  Dosage: Act.dis: Take in morn.& do not chew caps. Recomm.dly.  Ulc.colit: Ac.treatm. Adults: Indiv. Up to 4 g once dly/div.dos.
   (S4) OINT, [N/P/S in C] E/11.8/0667.  dos.is 9 mg once dly for up to 8 wks. Full effect achiev.within 2-4 wks.   Childr.6 yrs & old: Indiv. start. with 30-50 mg/kg/day in div.dos.
   762660-007: 15 g, R158,07    Taper off bef.cessat. Limit.exper.in elderly.  Max.75 mg/kg/ day in div.dos.with tot.dos.not exceed.4 g/day. Maint:
   762660-015: 30 g, R316,20    Contraindications: Loc.& syst. bact., fung.& vir.infects., safety &   Adults: Recomm.2 g once dly/div.dos. Childr.6 yrs.& old: Indiv.
   Dosage: Apply 2xdly., up to 4x dly.on 1st day. Max.7days.  effic.not est.in childr.  Init.15-30 mg/kg/day in div.dos.with tot.dos.not exceed.2 g/day. Chil-
   (S4) SUPPS, [N/P/S in C] E/11.8/0668  Side effects: GI disturbs., skin & subcut.tiss. reacts., psych.disords.,   dr. with bm up to 40 kg: Half adult dos. & norm.adult dos.above 40 kg.
   Prednisolone caproate 1,3 mg, cinchocaine HCl 1 mg/supp.  endocr.disords., musc. cramps, trem., S/E typic.of syst.glucocorticos-  Chron’s dis: Act.& maint.treatm: Adults: Indiv. Up to 4 g dly.in div.
   875384-005: 12, R194,37      ter., caps also: palpitat., nervousn., blurr.vis., menstr. disords., hypoka-  dos. Childr.6 yrs.& old: Act. dis.treatm: Indiv. Init.30-50 mg/kg/day
   Dosage: Insert 1 supp.high PR dly. If sympts.sev. insert 1 supp.2-  laem., growth.veloc.reduc., Cushingoid features  in div. dos.. Max: 75 mg/kg/day in div.dos. Tot.dos.not exceed.4 g/
       st
   3 xdly for 1  day.           Warnings and special precautions: Pregn.& lactat., pts. transfer.  day. Maint: Indiv. Init.15-30 mg/kg/ day in div.dos. Tot.dly.dos.not ex-
   Contraindications: Loc.vir, bact./fung.infects., second. untreat.   from syst. steroids. Caps also: TB, system./loc.infects., hypertens.,   ceed.4 g/day. Half adult dos.in childr.with bm of up to 40 kg & norm.
   skin infects., pregn.        diab.mellit., osteoporos., pept.ulc., glauc., cataracts, family hist.of   adult dos. above 40 kg.
   Side effects: Adren.suppress., skin atrophy risk, syst.absorpt.,   Contraindications: Salicyl.sens., childr., sev. liv./ren.impairm., safety
   allerg.reacts.               diab./glauc., other condits.where glucocorticoster.may have unwant.   in pregn.& lactat.not est.
                                effs., in stress situat.supplem.syst. glucocorticoster. recomm., chicken
   Special precautions: Addit.ther.in fung./ second. infect., bleed.,   Side effects: Bld.dyscras., myocardit., pericardit., GI disturbs.incl.
   infts., occlus.dress.        pox & measles may have a more ser. course in pts on oral budesonide   aggravat.of ulcerat. colit./cheilit & melaena, headache, dizzin., rash,
                                so avoid expos.& immune globulin may be indicat., allerg.unmask. dur.
   See also MDR page 254.                                     hypersens. & allerg.reacts., periph.neuropathy incl.Guillain-Barre
                                withdraw.phase.if syst.glucocortic.treatm. replac., HPA axis response
                                to stress reduc., comprom.hepat.funct.reduc.eliminat.  syndr., incr.amylase, pancreatit., revers.alopec., cardiomyopathy,
                                Drug interactions: Incr. system.expos. with concom.ketoconazole.&   allerg & fibrot.lung reacts., incr.liv.enzymes & bilirubin, hepatotox.,
   12.10  Others                grapefruit juice, oestrog./ OC’s enhanc.effs.  myalg., arthralg., urticar., lupus erythematosus-like reacts., imp.ren.
                                                              funct., loc. reacts.follow.rect.admin., drug fev., pancolit., oligosperm.
   MEZAVANT (MDR Listing)       INTEFLORA, Dr Reddys [P/S]    Warnings and special precautions Ren. damage, proteinur., reg.
   PENTASA (MDR Listing)        Saccharomyces boulardii CNCM 1-745  ren funct.monit.esp.dur. init.treatm.phase, suspect induc.nephrotoxic.
   REVELLEX (MDR Listing)       Indications: Prophpylax.& treatm.of intest.& muco-cutan.S/E induc.  if ren.dysfunct.develops dur.treatm., discont. treatm. if myocardit./
                                by antibiot.ther., non-specif. diarrh., colit.,enterocolit., diarrh.prevent.
                                                              pericardit.suspect./in case of ac.intol.sympt., concurr.preps.which
   ASACOL, Equity [P/S]         dur.contin. enteral feed.     low.stool pH., cross.placent.barr.& excret.in breast milk, elderly, imp.
   Mesalazine (5-aminosalicylic acid).  (S0) CAPS. T 194      liv.funct., determ.liv.funct.& differential bld.counts prior to & at reg.
   Indications: Treatm.& maint.of remiss.in ulcerat. colit.  700485-003: 250 mg, 10, R61,99  interv. dur.treatm., sulfasalazine sens., monit.pulm.dis. esp. asthma.
   (S3) TABS. [P/S] S/11.10/171  700485-005: 250 mg, 20, R123,97  Drug interactions: Prep.low.stool pH prev. release of act. ingred.,
   783668-007: 400 mg, 90, R650,59  Dosage: Adults, elderly, infts.& childr: 1cap 2xdly or as prescrib.  incr.ren.react.risk with other concom.nephrotox.agents, incr bld.
   Dosage: Adjust dos.accord.to respons. Adults:              dycras. risk with concom.azathioprine/6-mercaptopurine, poss.
   Induct.of remiss: 2,4 g (6 tabs.)once dly or in div.dos.2-3xdly. If   MEZAVANT, AI Pharm Ltd [P/S] &  decr.warfar.eff.
   necess.may be incr.to 4,8 g(12 tabs.)in div.dos.2-3xdly.  Mesalazine  See also MDR page 337-342.
   Maint of remiss: 1,6-2,4 g (4-6 tabs.)once dly or in div.dos.2-3xdly.  Indications: Treatm.& maint.of remiss.in ulcerat. colit.
   (S3) TABS. [P/S] 37/11.10/0629.  (S3) PR TABS. 45/11/0463  REVELLEX, Janssen [P/S] &
   709076-001: 800 mg, 60, R867,61  720355-001: 1 200 mg, 60, R1 148,65  Infliximab.
   Dosage: Adjust dos.accord.to respons. Max.dos not to exceed   Dosage: Admin.tabs without crush./chew.once dly.with/-out food.   Indications: Mod.to sev.act.adult/paed.Crohn’s dis.when respons.
   6 tabs/day and not to exceed 3 tabs taken at any one time.  Adults incl.elderly (&gt;65 yrs): Remiss.induct: 2,4-4,8 g once dly.   to convent.ther.inadeq., reduct.in the numb.of drain. enterocutan.&
   Adults:                      Treatm.eval.at 8 wks when max. 4,8 g/day is used.  rectovagin.fistula and maint.of fistula clos.in fistulis.Crohn’s dis., act.
   Mild ac.dis: 2,4 g (3 tabs.)once dly or in div.dos.2-3xdly.with concom.  Maint.remiss: 2,4 g once dly.  ulcerat.colit. in adults & paeds.where respons.to convent.ther.inadeq.
   corticoster.if clinic.indicat.  Contraindications: Salicyl.sens., sev.ren./hepat. impairm.,   (S4) POWD.FOR INFUS, 33/30.1/0531
   Mod ac.dis: 2,4-4,8 g (3-6 tabs.) in div.dos.2-3xdly.with concom.corti-  safety in porphyr./pregn.& lactat.not est., safety & effic. in childr.  707507-001: 100 mg, R5 569,07
   coster.if clinic.indicat. Dos.of 2,4 g may be taken once dly or in div.dos.  bel.18 yrs.not est.  Dosage: See product lit.for prep.& admin.techniq. Safety & effic.be-
   Maint.ther.: 1,6-2,4 g (2-3 tabs.)once dly or in div. dos.2-3xdly.  Side effects: Hypersens., anaphylact.react., drug reacts.with eosino-  yond recomm.durat.not est. Admin. by exper.physic.only. Observ.for
   (S3) ENEMA. [P/S] Z/11.10/205. 2 g/50 ml  phil.& system.sympts.(DRESS), GI disturbs.incl.flatul./naus., abdom.  1-2 hrs. post infus. Facilit.for treat.anaphylax.to be avail.
   824127-005: Sngl.enema, R181,99  distent./-pain, colit., dyspeps., vomit., headache, dizzin., somnol., hy-  Mod to sev.Chron’s dis: Re-admin.not recomm. aft. 16 wk.med.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page220.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page216.html">216</a>&nbsp;&nbsp;&nbsp;<a href="page217.html">217</a>&nbsp;&nbsp;&nbsp;<a href="page218.html">218</a>&nbsp;&nbsp;&nbsp;<a href="page219.html">219</a>&nbsp;&nbsp;&nbsp;<a href="page220.html">220</a>&nbsp;&nbsp;&nbsp;<a href="page221.html">221</a>&nbsp;&nbsp;&nbsp;<a href="page222.html">222</a>&nbsp;&nbsp;&nbsp;<a href="page223.html">223</a>&nbsp;&nbsp;&nbsp;<a href="page224.html">224</a>&nbsp;&nbsp;&nbsp;<a href="page225.html">225</a>&nbsp;&nbsp;&nbsp;<a href="page226.html">226</a>
             </td>
             <td width="35%"><a href="page222.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page222.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
